Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1977-03-01
1980-05-13
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 12, 23230B, G01N 3316, A61K 4300
Patent
active
042028728
ABSTRACT:
A test for determining the anti-coagulation level in blood samples is based on ascertaining the presence of heparin-antithrombin-III complex therein. This may be done with the aid of antibodies against thrombin-antithrombin-III complex, such antibodies being used e.g. in the form of a latex reagent or a bloodcell reagent.
REFERENCES:
Merskey et al., Proc. Soc. Exp. Biol. Med., vol. 131, No. 3, Jul., 1969, pp. 871-875.
Einarsson et al., Biochemica et Biphysica Acta, vol. 490, No. 1, Jan., 1977, pp. 104-111.
Collin et al., Thrombosis Research, vol. 7, No. 1, Jul., 1975, pp. 235-238.
Eslinger Lewis H.
Leuven Research & Development v.z.w.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Determination of heparin in blood plasma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Determination of heparin in blood plasma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Determination of heparin in blood plasma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-929741